GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · Real-Time Price · USD
158.96
-2.99 (-1.85%)
At close: Dec 5, 2025, 4:00 PM EST
157.50
-1.46 (-0.92%)
After-hours: Dec 5, 2025, 7:46 PM EST
GeneDx Holdings Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2018 |
| Operating Revenue | 393.58 | 302.16 | 195.65 | 227.33 | 205.1 | 175.35 | Upgrade
|
| Other Revenue | 8.61 | 3.29 | 6.91 | 7.36 | 7.1 | 3.97 | Upgrade
|
| Revenue | 402.19 | 305.45 | 202.57 | 234.69 | 212.2 | 179.32 | Upgrade
|
| Revenue Growth (YoY) | 50.50% | 50.79% | -13.69% | 10.60% | 18.33% | -8.59% | Upgrade
|
| Cost of Revenue | 122.08 | 111 | 116.06 | 261.44 | 228.8 | 155.73 | Upgrade
|
| Gross Profit | 280.11 | 194.45 | 86.51 | -26.75 | -16.6 | 23.6 | Upgrade
|
| Selling, General & Admin | 206.12 | 166.93 | 191.49 | 338.24 | 324.39 | 173.32 | Upgrade
|
| Research & Development | 58.92 | 45.57 | 55.09 | 86.2 | 105.16 | 72.7 | Upgrade
|
| Other Operating Expenses | 3.41 | 3.41 | 5.27 | 6.31 | - | - | Upgrade
|
| Operating Expenses | 268.45 | 215.91 | 251.85 | 430.76 | 429.55 | 246.02 | Upgrade
|
| Operating Income | 11.66 | -21.46 | -165.34 | -457.51 | -446.15 | -222.42 | Upgrade
|
| Interest Expense | -2.72 | -3.03 | - | -0.67 | -2.84 | -2.47 | Upgrade
|
| Interest & Investment Income | - | - | 1.11 | - | 0.08 | 0.51 | Upgrade
|
| Other Non Operating Income (Expenses) | 11.45 | -13.6 | 1.17 | 70.29 | 198.22 | 0.02 | Upgrade
|
| EBT Excluding Unusual Items | 20.39 | -38.09 | -163.06 | -387.89 | -250.69 | -224.37 | Upgrade
|
| Merger & Restructuring Charges | -1.7 | -1.75 | -6.53 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | 1.68 | - | - | - | Upgrade
|
| Asset Writedown | - | - | -10.4 | -210.15 | - | - | Upgrade
|
| Legal Settlements | -12.79 | -12.79 | - | - | - | - | Upgrade
|
| Other Unusual Items | -3.4 | - | 1.62 | - | 5.3 | -16.97 | Upgrade
|
| Pretax Income | 2.51 | -52.63 | -176.69 | -598.03 | -245.39 | -241.34 | Upgrade
|
| Income Tax Expense | 0.42 | -0.34 | -0.93 | -49.05 | - | - | Upgrade
|
| Net Income | 2.08 | -52.29 | -175.77 | -548.98 | -245.39 | -241.34 | Upgrade
|
| Net Income to Common | 2.08 | -52.29 | -175.77 | -548.98 | -245.39 | -241.34 | Upgrade
|
| Shares Outstanding (Basic) | 28 | 27 | 24 | 10 | 3 | - | Upgrade
|
| Shares Outstanding (Diluted) | 28 | 27 | 24 | 10 | 3 | - | Upgrade
|
| Shares Change (YoY) | 7.19% | 10.61% | 137.49% | 212.57% | - | - | Upgrade
|
| EPS (Basic) | 0.07 | -1.94 | -7.23 | -53.63 | -74.93 | - | Upgrade
|
| EPS (Diluted) | 0.07 | -1.94 | -7.23 | -53.63 | -74.93 | - | Upgrade
|
| Free Cash Flow | 15.47 | -33.99 | -185.4 | -326.31 | -199.83 | -117.22 | Upgrade
|
| Free Cash Flow Per Share | 0.55 | -1.26 | -7.63 | -31.88 | -61.02 | - | Upgrade
|
| Gross Margin | 69.65% | 63.66% | 42.71% | -11.40% | -7.82% | 13.16% | Upgrade
|
| Operating Margin | 2.90% | -7.03% | -81.62% | -194.94% | -210.25% | -124.04% | Upgrade
|
| Profit Margin | 0.52% | -17.12% | -86.77% | -233.91% | -115.64% | -134.59% | Upgrade
|
| Free Cash Flow Margin | 3.84% | -11.13% | -91.52% | -139.04% | -94.17% | -65.37% | Upgrade
|
| EBITDA | 34.66 | -0.41 | -138.21 | -413.6 | -429.94 | -213.69 | Upgrade
|
| EBITDA Margin | 8.62% | -0.13% | -68.23% | -176.23% | -202.62% | -119.17% | Upgrade
|
| D&A For EBITDA | 23 | 21.05 | 27.13 | 43.91 | 16.21 | 8.73 | Upgrade
|
| EBIT | 11.66 | -21.46 | -165.34 | -457.51 | -446.15 | -222.42 | Upgrade
|
| EBIT Margin | 2.90% | -7.03% | -81.62% | -194.94% | -210.25% | -124.04% | Upgrade
|
| Revenue as Reported | 402.19 | 305.45 | 202.57 | 234.69 | 212.2 | 179.32 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.